Low dose initiation of buprenorphine: a narrative review and practical approach

SM Cohen, MB Weimer, XA Levander… - Journal of addiction …, 2022 - journals.lww.com
Low dose buprenorphine initiation, is an alternative method of initiating buprenorphine in
which the starting dose is very low and gradually increased to therapeutic levels over a …

Opioid use disorder

JL Taylor, JH Samet - Annals of Internal Medicine, 2022 - acpjournals.org
Opioid use disorder (OUD) is a treatable chronic disorder with episodes of remission and
recurrence characterized by loss of control of opioid use, compulsive use, and continued …

Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl

NB Varshneya, AP Thakrar… - Journal of addiction …, 2022 - journals.lww.com
Objectives: Buprenorphine can precipitate withdrawal in opioid-dependent persons with
recent fentanyl use. However, the prevalence of this phenomenon is not clinically …

Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper

AS Huhn, PH Finan, CE Gamaldo… - Science translational …, 2022 - science.org
Increased orexin/hypocretin signaling is implicated in opioid withdrawal, sleep disturbances,
and drug-seeking behaviors. This study examined whether a dual-orexin receptor …

Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl

LC Chambers, BD Hallowell, AR Zullo… - JAMA Network …, 2023 - jamanetwork.com
Importance Buprenorphine treatment for opioid use disorder (OUD) has more than doubled
since 2009. However, current US Food and Drug Administration buprenorphine dosing …

Protracted renal clearance of fentanyl in persons with opioid use disorder

AS Huhn, JG Hobelmann, GA Oyler… - Drug and alcohol …, 2020 - Elsevier
Introduction The illicit opioid supply in the US is increasingly adulterated with fentanyl. As
such, persons with opioid use disorder (OUD) may be regularly exposed to fentanyl …

Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl

A Spadaro, A Sarker, W Hogg-Bremer, JS Love… - Clinical …, 2022 - Taylor & Francis
Background Induction of buprenorphine, an evidence-based treatment for opioid use
disorder (OUD), has been reported to be difficult for people with heavy use of fentanyl, the …

Fentanyl absorption, distribution, metabolism, and excretion: Narrative review and clinical significance related to illicitly manufactured fentanyl

HE Bird, AS Huhn, KE Dunn - Journal of addiction medicine, 2023 - journals.lww.com
Objectives This narrative review summarizes literature on pharmaceutical fentanyl's
absorption, distribution, metabolism, and excretion patterns to inform research on illicitly …

Shifting North American drug markets and challenges for the system of care

RM Krausz, JN Westenberg, N Mathew, G Budd… - International Journal of …, 2021 - Springer
Drug markets are dynamic systems which change based on demand, competition,
legislation and revenue. Shifts that are not met with immediate and appropriate responses …

A neuropharmacological model to explain buprenorphine induction challenges

MK Greenwald, AA Herring, J Perrone… - Annals of Emergency …, 2022 - Elsevier
Buprenorphine induction for treating opioid use disorder is being implemented in
emergency care. During this era of high-potency synthetic opioid use, novel and divergent …